Sanofi

Sanofi is an Investment Adviser institutional filer with the SEC under CIK 1121404, reporting 10 portfolio positions, with 7 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

• Sector: Pharmaceutical Preparations
• State of incorporation: I0
• Filing type: 13F-HR
• Latest reporting period: 2026-06-30
• Last filed: 2026-07-28

Top 10 portfolio positions

The largest reported holdings in Sanofi's most recent 13F filing, ranked by reported market value.

1. MeiraGTx Holdings plc (MGTX)
2. Inhibrx Biosciences, Inc. (INBX)
3. Novavax (NVAX)
4. AnaptysBio (ANAB)
5. Odyssey Therapeutics Inc. (ODTX)
6. Agomab Therapeutics NV (AGMB)
7. MapLight Therapeutics Inc. (MPLT)
8. First Tracks Biotherapeutics Inc. (TRAX)
9. Immuneering Corp (IMRX)
10. Q32 Bio Inc. (QTTB)